This looks like the crossing of a threshold in the effort to produce replacement human pancreatic beta cells that are glucose-responsive and transplantable as a personalized cell replacement therapy for diabetes.
This looks like the crossing of a threshold in the effort to produce replacement human pancreatic beta cells that are glucose-responsive and transplantable as a personalized cell replacement therapy for diabetes.